Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10456)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 7, 2020 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xu XY, Ding HG, Li WG, Xu JH, Han Y, Jia JD, Wei L, Duan ZP, Ling-Hu EQ, Zhuang H. Chinese guidelines on the management of liver cirrhosis (abbreviated version) . World J Gastroenterol 2020; 26(45): 7088-7103 [PMID: 33362370 DOI: 10.3748/wjg.v26.i45.7088] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v26/i45/7088.htm |
| Number | Citing Articles |
| 1 |
Ka Zhang, Yifan Jia, Xin Shu, Xiaoan Yang, Haixia Sun, Hong Cao, Yongyu Mei, Canhui Xiao. Relationship Between Platelets and the Clinical Efficacy of Umbilical Cord Mesenchymal Stem Cells for HBV-Related Acute-on-Chronic Liver Failure and Liver Cirrhosis: A Preliminary Clinical Study. Stem Cells Translational Medicine 2023; 12(6): 325 doi: 10.1093/stcltm/szad023
|
| 2 |
Gui-Xiang Qian, Zi-Ling Xu, Yong-Hai Li, Jian-Lin Lu, Xiang-Yi Bu, Ming-Tong Wei, Wei-Dong Jia. Computed tomography-based radiomics to predict early recurrence of hepatocellular carcinoma post-hepatectomy in patients background on cirrhosis. World Journal of Gastroenterology 2024; 30(15): 2128-2142 doi: 10.3748/wjg.v30.i15.2128
|
| 3 |
Lisa S. Parks, Patricia Little. Cirrhosis, Hepatocellular Carcinoma, and Locoregional Therapies. Journal of Radiology Nursing 2022; 41(2): 129 doi: 10.1016/j.jradnu.2022.01.005
|
| 4 |
Yingying Zhao, Song Yang, Huichun Xing. Pulmonary Bacterial Infection and Liver Cirrhosis: Current Status and Treatment. Infectious Microbes and Diseases 2023; doi: 10.1097/IM9.0000000000000137
|
| 5 |
Anton Gillessen, Francesco Angelico, Jun Chen, Lungen Lu, Maria Isabel Lucena, Qingchun Fu, Qing Xie, Raul J. Andrade, Wen Xie, Xiaoyuan Xu, Yanyan Yu, Yi-min Mao, Yuemin Nan. Silymarin for Treating Toxic Liver Disease: International Consensus Recommendations. Gastro Hep Advances 2022; 1(5): 882 doi: 10.1016/j.gastha.2022.05.006
|
| 6 |
Zhiying He, Bingqiong Wang, Xiaoning Wu, Zhongjie Hu, Chunqing Zhang, Yanqin Hao, Yongfeng Yang, Yan Huang, Wei Rao, Jing Wang, Jialing Zhou, Shuai Xia, Xiaojuan Ou, Jidong Jia, Hong You. Recompensation in treatment-naïve HBV-related decompensated cirrhosis: a 5-year multi-center observational study comparing patients with ascites and bleeding. Hepatology International 2023; 17(6): 1368 doi: 10.1007/s12072-023-10579-w
|
| 7 |
Qian Yang, Hua Ye, Guiying Sun, Keyan Wang, Liping Dai, Cuipeng Qiu, Jianxiang Shi, Jicun Zhu, Xiao Wang, Peng Wang. Human Proteome Microarray identifies autoantibodies to tumor‐associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma. Molecular Oncology 2023; 17(5): 887 doi: 10.1002/1878-0261.13371
|
| 8 |
Shan Tang, Xiaodan Zhang, Zhongping Duan, Manman Xu, Ming Kong, Sujun Zheng, Li Bai, Yu Chen. The novel hepatoprotective mechanisms of silibinin-phospholipid complex against d-GalN/LPS-induced acute liver injury. International Immunopharmacology 2023; 116: 109808 doi: 10.1016/j.intimp.2023.109808
|
| 9 |
Weiqiang Gan, Youming Chen, Zeqian Wu, Yingfu Zeng, Zhiliang Gao, Yongyu Mei. Characteristics of Patients with Cryptogenic Cirrhosis: A Retrospective Study. Diseases and Research 2021; 1(1): 14 doi: 10.54457/DR.2021010004
|
| 10 |
Xiaojing Wu, Junqi Niu, Ying Shi. Exosomes target HBV-host interactions to remodel the hepatic immune microenvironment. Journal of Nanobiotechnology 2024; 22(1) doi: 10.1186/s12951-024-02544-y
|
| 11 |
Yijie Yan, Yue Li, Chunlei Fan, Yuening Zhang, Shibin Zhang, Zhi Wang, Tehui Huang, Zhenjia Ding, Keqin Hu, Lei Li, Huiguo Ding. A novel machine learning-based radiomic model for diagnosing high bleeding risk esophageal varices in cirrhotic patients. Hepatology International 2022; 16(2): 423 doi: 10.1007/s12072-021-10292-6
|
| 12 |
Miaochan Wang, Yujiao Jin, Aifang Xu. Diagnostic and prognostic value of quantitative detection of antimitochondrial antibodies subtype M2 using chemiluminescence immunoassay in primary biliary cholangitis. Clinical Chemistry and Laboratory Medicine (CCLM) 2024; 62(2): e53 doi: 10.1515/cclm-2023-0742
|
| 13 |
Lei Xu, Lin Chen, Bin Zhang, Zhicheng Liu, Qiumeng Liu, Huifang Liang, Yifa Chen, Xiaoping Chen, Chao Leng, Bixiang Zhang. Alkaline phosphatase combined with γ-glutamyl transferase is an independent predictor of prognosis of hepatocellular carcinoma patients receiving programmed death-1 inhibitors. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1115706
|
| 14 |
Rong Wang, Keying Jing, Yang Liu, Huijuan Zhao, Jun Cai. Viral hepatitis is associated with increased risk of decompensated cirrhosis or liver failure in patients positive for liver cytosol antibody type 1. Scandinavian Journal of Immunology 2023; 98(2) doi: 10.1111/sji.13281
|
| 15 |
Qiao Ke, Xueping Yu, Xuan Wang, Jinfa Huang, Biding Lin, Jian He, Zhiyong Wang, Xinhui Huang, Xiadi Weng, Yubin Jiao, Yixing Xie, Weimin Wu, Linbin Qiu, Ling Li, Zhengju Xu, Zhijun Su, Yuzhen Zhuge, Jingfeng Liu, Wuhua Guo. Prevalence, clinical characteristics, and outcomes of spontaneous portosystemic shunt in patients with hepatitis B-related cirrhosis: A multicenter study from China. Digestive and Liver Disease 2023; 55(10): 1382 doi: 10.1016/j.dld.2023.04.012
|
| 16 |
Di Meng, Shuang Ren. Mairin from Huangqi Decoction Mitigates Liver Cirrhosis through
Suppression of Pro-inflammatory Signaling Pathways: A Network
Pharmacology and Experimental Study. The Natural Products Journal 2024; 14(5) doi: 10.2174/0122103155273345231210170121
|
| 17 |
Dandan Zhao, Songhao Yu, Peilin Guo, Xiaoxiao Zhang, Yuhui Tang, Chen Dong, Suxian Zhao, Lu Li, Zaid Al‐Dhamin, Rong Ai, Ningning Xue, Shiming Dong, Yuemin Nan. Identification of potential plasma markers for hepatitis B virus‐related chronic hepatitis and liver fibrosis/cirrhosis. Journal of Medical Virology 2022; 94(8): 3900 doi: 10.1002/jmv.27761
|
| 18 |
Rong Chen, Ling Luo, Yun-Zhi Zhang, Zhen Liu, An-Lin Liu, Yi-Wen Zhang. Bayesian network-based survival prediction model for patients having undergone post-transjugular intrahepatic portosystemic shunt for portal hypertension. World Journal of Gastroenterology 2024; 30(13): 1859-1870 doi: 10.3748/wjg.v30.i13.1859
|
| 19 |
Zhengyu Xu, Dawei Yang, Jia Luo, Hui Xu, Jidong Jia, Zhenghan Yang. Diagnosis of Sarcopenia Using the L3 Skeletal Muscle Index Estimated From the L1 Skeletal Muscle Index on MR Images in Patients With Cirrhosis. Journal of Magnetic Resonance Imaging 2023; 58(5): 1569 doi: 10.1002/jmri.28690
|
| 20 |
Ruonan Sun, Jiawei Li, Xianyi Lin, Yidong Yang, Bing Liu, Tianbi Lan, Shuang Xiao, Anyi Deng, Zhinan Yin, Yan Xu, Zheng Xiang, Bin Wu. Peripheral immune characteristics of hepatitis B virus-related hepatocellular carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1079495
|
| 21 |
Nan Chen, Yu Sun, Pengyu Luo, Yuna Tang, Yuchen Fan, Liyan Han, Kai Wang. Association of CXCR4 gene expression and promoter methylation with chronic hepatitis B-related fibrosis/cirrhosis. International Immunopharmacology 2024; 139: 112686 doi: 10.1016/j.intimp.2024.112686
|
| 22 |
Taiyu He, Yingzhi Zhou, Pan Xu, Ning Ling, Min Chen, Tianquan Huang, Biqiong Zhang, Ziqiao Yang, Ling Ao, Hu Li, Zhiwei Chen, Dazhi Zhang, Xiaofeng Shi, Yu Lei, Zhiyi Wang, Weiqun Zeng, Peng Hu, Yinghua Lan, Zhi Zhou, Juan Kang, Ying Huang, Tongdong Shi, Qingbo Pan, Qian Zhu, Xiping Ran, Yingzhi Zhang, Rui Song, Dejuan Xiang, Shuang Xiao, Gaoli Zhang, Wei Shen, Mingli Peng, Dachuan Cai, Hong Ren. Safety and antibody response to inactivated COVID‐19 vaccine in patients with chronic hepatitis B virus infection. Liver International 2022; 42(6): 1287 doi: 10.1111/liv.15173
|
| 23 |
Zhiying He, Jialing Zhou, Yu Tian, Shanshan Wu, Yameng Sun, Xiaojuan Ou, Jidong Jia, Bingqiong Wang, Xiaoning Wu, Hong You. Two-year free of complications during antiviral therapy predicts stable re-compensation in immediate-treatment HBV-related decompensated cirrhosis. Scandinavian Journal of Gastroenterology 2023; 58(4): 403 doi: 10.1080/00365521.2022.2132532
|
| 24 |
Nan Geng, Ming Kong, Jiateng Zhang, Huina Chen, Manman Xu, Wenyan Song, Yu Chen, Zhongping Duan. Association of myosteatosis with short-term outcomes in patients with acute-on-chronic liver failure. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-64420-x
|
| 25 |
Qiao Ke, Jian He, Xinhui Huang, Ling Li, Jingfeng Liu, Wuhua Guo. Spontaneous portosystemic shunts outside the esophago-gastric region: Prevalence, clinical characteristics, and impact on mortality in cirrhotic patients: A systematic review and meta-analysis. European Journal of Internal Medicine 2023; 112: 77 doi: 10.1016/j.ejim.2023.03.024
|
| 26 |
Qiao Ke, Zhiyong Wang, Xinhui Huang, Ling Li, Weimin Wu, Linbin Qiu, Yubin Jiao, Yixing Xie, Xiaosong Peng, Jingfeng Liu, Wuhua Guo. Splenic vein embolization as a feasible treatment for patients with hepatic encephalopathy related to large spontaneous splenorenal shunts. Annals of Hepatology 2022; 27(5): 100725 doi: 10.1016/j.aohep.2022.100725
|
| 27 |
Shanghao Liu, Jianzhong Ma, Ping Chen, Shirong Liu, Ying Guo, Mingjie Tan, Xiaoqing Guo, Yinong Feng, Qinghui Wang, Wenhua Li, Chengchen Yang, Bo Gao, Yongli Hua, Ning Liu, Haolin Song, Ruiling He, Ruiying Wang, Qi Gao, Chuan Liu, Xiaolong Qi. Novel serum biomarker of Golgi protein 73 for the diagnosis of clinically significant portal hypertension in patients with compensated cirrhosis. Journal of Medical Virology 2024; 96(1) doi: 10.1002/jmv.29380
|
| 28 |
Yuan-Yao Zhang, Zhong-Ji Meng. Definition and classification of acute-on-chronic liver diseases. World Journal of Clinical Cases 2022; 10(15): 4717-4725 doi: 10.12998/wjcc.v10.i15.4717
|
| 29 |
Dan-Tong Zhao, Hui-Ping Yan, Hui-Yu Liao, Yan-Min Liu, Ying Han, Hai-Ping Zhang, Wei-Ming Zhang, Chun-Yang Huang, Xiu-Hong Liu, Jin-Li Lou, Yan Zhao. Using two-step cluster analysis to classify inpatients with primary biliary cholangitis based on autoantibodies: A real-world retrospective study of 537 patients in China. Frontiers in Immunology 2023; 13 doi: 10.3389/fimmu.2022.1098076
|
| 30 |
Dan-Tong Zhao, Hui-Ping Yan, Ying Han, Wei-Ming Zhang, Yan Zhao, Hui-Yu Liao. Prevalence and prognostic significance of main metabolic risk factors in primary biliary cholangitis: a retrospective cohort study of 789 patients. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1142177
|
| 31 |
Jin Cheng, Honglei Ju, Guixiang Wang, Chiyi He, Wei Wang. Association of Systemic Inflammation Response Index with Short-Term All-Cause Mortality in Decompensated Liver Cirrhosis Patients. Journal of Inflammation Research 2024; : 8985 doi: 10.2147/JIR.S476743
|
| 32 |
Da Zhou, Yifan Shi, Donghua Zhang, Junbo Zuo, Chenghao Zeng, Gulsudum Mamtawla, LongChang Huang, Xuejin Gao, Li Zhang, Xinying Wang. Liver-secreted FGF21 induces sarcopenia by inhibiting satellite cell myogenesis via klotho beta in decompensated cirrhosis. Redox Biology 2024; 76: 103333 doi: 10.1016/j.redox.2024.103333
|
| 33 |
Yanjing Wu, Yongle Wu, Kun Liu, Hui Liu, Shanshan Wang, Jian Huang, Huiguo Ding. Identification of Genetic Predisposition in Noncirrhotic Portal Hypertension Patients With Multiple Renal Cysts by Integrated Analysis of Whole-Genome and Single-Cell RNA Sequencing. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.775470
|
| 34 |
Ying Hao Cao, Ping Chi, Chen Zhou, Wen Fei Lv, Zhe Fen Quan, Fu Shan Xue. The 50% and 95% effective doses of remimazolam tosilate with adjuvant sufentanil for sedation in patients with liver cirrhosis undergoing oesophagogastric varices screening endoscopy. Journal of Clinical Pharmacy and Therapeutics 2022; 47(12): 2068 doi: 10.1111/jcpt.13751
|
| 35 |
Yan Li, Meng-Jun Zhang, Xue-Hong Wang, Su-Hua Li. Novel noninvasive indices for the assessment of liver fibrosis in primary biliary cholangitis. Biomedical Reports 2023; 20(1) doi: 10.3892/br.2023.1689
|
| 36 |
Caie Wang, Ghid Kanaan, Yiyang Shang, Lu Chai, Hui Li, Xingshun Qi. Silymarin for treatment of adults with nonalcoholic fatty liver disease. Cochrane Database of Systematic Reviews 2023; 2023(4) doi: 10.1002/14651858.CD015524
|
| 37 |
Dianqiang Lu, Zhengyan Jiang, Xuezhen Zhai, Zhiguang Sun, Ahmed Faeq Hussein. Prognostic Analysis of Liver Cirrhosis Patients with Cerebral Infarction and/or Gastrointestinal Hemorrhage: A Retrospective Cohort Study. Computational and Mathematical Methods in Medicine 2022; 2022: 1 doi: 10.1155/2022/2566746
|
| 38 |
Yuanxun Yue, Zhizhong Ren, Yaqin Wang, Ying Liu, Xiaowei Yang, Tianxiao Wang, Yating Bai, He Zhou, Qian Chen, Sujun Li, Yuewei Zhang. Impact of Microparticle Transarterial Chemoembolization (mTACE) on myeloid‐derived suppressor cell subtypes in hepatocellular carcinoma: Clinical correlations and therapeutic implications. Immunity, Inflammation and Disease 2024; 12(9) doi: 10.1002/iid3.70007
|
| 39 |
Jie Cheng, Kai Huang, Juan-Li Mou, Yao-Jia Lao, Jia-Hui Feng, Fan Hu, Meng-Lu Lin, Tangnuer Maimaitiaishan, Jian Shang, Jun Lin. Prognosis value of serum chloride on 1-year mortality in cirrhotic patients receiving transjugular intrahepatic portosystemic shunt. Journal of the Formosan Medical Association 2023; 122(9): 911 doi: 10.1016/j.jfma.2023.02.009
|
| 40 |
Zhou Yu, Dongmei Chen, Yansong Zheng, Xuedan Wang, Shuna Huang, Tiansheng Lin, Yihan Lin, Yanfang Zhang, Yingna Huang, Qishui Ou, Jinlan Huang. Development and validation of a diagnostic model for AFP-negative hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2023; 149(13): 11295 doi: 10.1007/s00432-023-04997-4
|
| 41 |
Fengbin Zhang, Yonghe Zhou, Xin Li, Chunyan Wang, Jie Liu, Shuang Li, Shuting Zhang, Weiming Luo, Lili Zhao, Jia Li. Spleen Thickness Plus Platelets Can Effectively and Safely Screen for High-Risk Varices in Cirrhosis Patients. Diagnostics 2023; 13(20): 3164 doi: 10.3390/diagnostics13203164
|
| 42 |
Xue-Fei Wei, Jin-Yu Zhu, Hui-Hui Liu, Xing Su, Ji-Hui Li, Yu-Chen Fan, Kai Wang. Hypomethylation of Tumor necrosis factor-like cytokine 1A(TL1A) and its decoy receptor 3 expressive level increase has diagnostic value in HBV-associated cirrhosis. Virology 2023; 585: 91 doi: 10.1016/j.virol.2023.04.009
|
| 43 |
Yinping Zhai, Darong Hai, Li Zeng, Chenyan Lin, Xinru Tan, Zefei Mo, Qijia Tao, Wenhui Li, Xiaowei Xu, Qi Zhao, Jianwei Shuai, Jingye Pan. Artificial intelligence-based evaluation of prognosis in cirrhosis. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05726-2
|
| 44 |
Yingjun Chen, Shaoxian Chen, Chandi Xu, Li Yu, Shanshan Chu, Jianzhi Bao, Jinwei Wang, Junwei Wang. Identification of Diagnostic Biomarkers for Compensatory Liver Cirrhosis Based on Gut Microbiota and Urine Metabolomics Analyses. Molecular Biotechnology 2024; 66(11): 3164 doi: 10.1007/s12033-023-00922-9
|
| 45 |
Chen Hui-ling, Huang Kang-ming, Zhao Yu, Deng Yin-han, Du Huang, Xiao Shu-ping, Chen Hong-bin. The potential value of serum GP73 in the ancillary diagnosis and grading of liver cirrhosis. Scandinavian Journal of Clinical and Laboratory Investigation 2023; 83(2): 95 doi: 10.1080/00365513.2023.2175238
|
| 46 |
Yuan Xu, Bei Zhang, Fan Zhou, Ying-ping Yi, Xin-Lei Yang, Xiao Ouyang, Hui Hu. Development of machine learning-based personalized predictive models for risk evaluation of hepatocellular carcinoma in hepatitis B virus-related cirrhosis patients with low levels of serum alpha-fetoprotein. Annals of Hepatology 2024; 29(6): 101540 doi: 10.1016/j.aohep.2024.101540
|
| 47 |
Li Siyu, Yuan Yuan, An Ran, Li Minyan. Frailty as tested by the Liver Frailty Index in out-patient patients with cirrhosis in China: a cross-sectional study. European Journal of Gastroenterology & Hepatology 2023; 35(4): 440 doi: 10.1097/MEG.0000000000002502
|
| 48 |
Yujiao Jin, Miaochan Wang, Yuan Liu, Aifang Xu. Antimitochondrial antibody associated with liver cirrhosis in patients with primary biliary cholangitis. Medicine 2023; 102(42): e35617 doi: 10.1097/MD.0000000000035617
|
| 49 |
Haoyu Wang, Fuquan Liu. Clinical characteristics of hepatopulmonary syndrome and hepatorenal syndrome and associated therapeutic potential of transjugular intrahepatic portosystemic shunt. iLIVER 2023; 2(1): 67 doi: 10.1016/j.iliver.2023.02.001
|
| 50 |
Min-Jun Liao, Jun Li, Wei Dang, Dong-Bo Chen, Wan-Ying Qin, Pu Chen, Bi-Geng Zhao, Li-Ying Ren, Ting-Feng Xu, Hong-Song Chen, Wei-Jia Liao. Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China. World Journal of Gastroenterology 2022; 28(27): 3503-3513 doi: 10.3748/wjg.v28.i27.3503
|
| 51 |
Xu Chen, Abdul Fatawu Mohammed, Chengbin Li. Assessment of the Clinical Value of Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma. Clinical and Applied Thrombosis/Hemostasis 2024; 30 doi: 10.1177/10760296231221535
|
| 52 |
Ming Luo, Rui-Juan Xin, Fang-Rui Hu, Li Yao, Sheng-Juan Hu, Fei-Hu Bai. Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy <i>via </i>the gut-liver-brain axis. World Journal of Gastroenterology 2023; 29(1): 144-156 doi: 10.3748/wjg.v29.i1.144
|
| 53 |
Zhihuai Wang, Peng Gao, Weijun Sun, Adeel ur Rehman, Jiakai Jiang, Suobao Xu, Cailin Xue, Chunfu Zhu, Xihu Qin. Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.938102
|